Related Experiment Video
Updated: Jun 20, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Activin inhibits telomerase activity in cancer
Indzi Katik1, Charley Mackenzie-Kludas, Craig Nicholls
1Department of Immunology, Monash University, Central Clinical School, Commercial Road, Melbourne, Vic. 3004, Australia.
Abstract:
Activin is a pleiotropic cytokine with broad tissue distributions. Recent studies demonstrate that activin-A inhibits cancer cell proliferation with unknown mechanisms. In this report, we demonstrate that recombinant activin-A induces telomerase inhibition in cancer cells. In breast and cervical cancer cells, activin-A resulted in telomerase activity in a concentration-dependent manner. Significant inhibition was observed at 10 ng/ml of activin-A, with a near complete inhibition at 80 ng/ml. Consistently, activin-A induced repression of the telomerase reverse transcriptase (hTERT) gene, with the hTERT gene to be suppressed by 60-80% within 24h. In addition, activin-A induced a concomitant increase in Smad3 signaling and decrease of the hTERT gene promoter activity in a concentration-dependent fashion. These data suggest that activin-A triggered telomerase inhibition by down-regulating hTERT gene expression is involved in activin-A-induced inhibition of cancer cell proliferation.
Insights
Activin-A inhibits cancer cell proliferation by suppressing telomerase activity. This involves down-regulating the human telomerase reverse transcriptase (hTERT) gene expression, offering a potential new therapeutic strategy.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Activin is a cytokine with diverse tissue distribution.
- Activin-A is known to inhibit cancer cell proliferation through mechanisms not fully understood.
Purpose of the Study:
- To investigate the mechanism by which activin-A inhibits cancer cell proliferation.
- To determine if activin-A affects telomerase activity and expression in cancer cells.
Main Methods:
- Treatment of breast and cervical cancer cells with recombinant activin-A.
- Assay of telomerase activity.
- Quantitative analysis of human telomerase reverse transcriptase (hTERT) gene expression.
- Measurement of Smad3 signaling and hTERT gene promoter activity.
Main Results:
- Recombinant activin-A inhibited telomerase activity in a concentration-dependent manner.
- Activin-A repressed hTERT gene expression by 60-80% within 24 hours.
- Activin-A increased Smad3 signaling and decreased hTERT gene promoter activity.
Conclusions:
- Activin-A-induced telomerase inhibition is mediated by down-regulation of hTERT gene expression.
- This mechanism contributes to activin-A's anti-proliferative effects on cancer cells.
Related Concept Videos
Replicative Cell Senescence
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Telomeres and Telomerase
Telomeres and Telomerase
The Intrinsic Apoptotic Pathway

